Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?
Read More 5 minute read Pharma Industry News GSK to acquire efimosfermin from Boston Pharmaceuticals for $2bn to bolster liver disease pipeline GSK acquires Phase III-ready efimosfermin from Boston Pharmaceuticals for $2B, expanding its liver disease pipeline with a fibrosis-reversing specialty drug. byPallavi MadhirajuMay 14, 2025